Episode 28: Brolucizumab for wet AMD (HAWK and HARRIER) - Dr. Pravin Dugel

Related

• 

  Efficacy, Durability, and Safety of Faricimab in DME: 2-Year Results From the Phase 3 YOSEMITE and RHINE Trials

  Jennifer I. Lim, MD, FARVO, FASRS

  Updates from the Field

  2022

• 

  Real-world U.S. outcomes of anti-VEGF therapy in diabetic macular edema

  Thomas A. Ciulla, MD, MBA, FASRS

  Updates from the Field

  2017

• 

  Interaction of Genotypes and AREDS Formulation Use in the Development of Neovascular AMD

  Pradeepa Yoganathan, MSc, MD, FRCS(C)

  Annual Meeting Talks

  2019